Selexis SA develops and provides technologies and services for mammalian cell line development, with a focus on biopharmaceutical production. The company also presents its SUREtechnology platform for stable CHO-based cell line development.
AI-generated
Offering
Products & services
Industry:Research & Development
✓ Offered8
Cell line development services
Services for mammalian and microbial expression systems, including development of cell lines for biological active ingredients.
Process development
Process development for new biologics with robust, reproducible and scalable processes throughout the early development phases.
Analytical development
Analytical development for biologics, including services across the entire project cycle and analytical support up to the GMP phase.
Formulation development
Formulation development using a data-driven approach to optimise formulations for biologics.
Characterisation
Characterisation for in-depth molecular analysis, including particle characterisation, biophysical characterisation and mass spectrometry.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.